Total planned funding: $243,101,278
Clear active filters
U.S. Centers for Disease Control and Prevention
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Uganda | $25,983,678 |
| Kenya | $25,131,868 |
| Nigeria | $20,638,969 |
| Ethiopia | $19,769,996 |
| Mozambique | $18,726,889 |
| Tanzania | $15,369,957 |
| South Africa | $15,162,722 |
| Botswana | $15,016,084 |
| Zambia | $15,007,830 |
| Côte d'Ivoire | $14,733,021 |
| Namibia | $9,294,685 |
| Vietnam | $8,383,940 |
| Rwanda | $5,551,244 |
| Zimbabwe | $4,955,000 |
| Haiti | $4,935,500 |
| Guyana | $3,406,909 |
| Malawi | $2,787,000 |
| India | $2,721,168 |
| Thailand | $2,597,880 |
| Angola | $2,100,000 |
| Dominican Republic | $2,004,000 |
| Cambodia | $1,918,835 |
| Democratic Republic of the Congo | $1,717,655 |
| South Sudan | $1,251,520 |
| Ghana | $1,000,000 |
| Eswatini | $989,928 |
| Russia | $760,000 |
| Lesotho | $705,000 |
| China | $480,000 |
Organizational Types
| Own Agency | $243,101,278 |
Program Areas
| Management and Operations | $91,773,135 |
| Governance and Systems | $52,793,414 |
| Prevention | $10,910,027 |
| Care | $8,626,232 |
| Treatment | $7,296,880 |
| Testing | $3,092,864 |
Budget Codes
| HVMS: Management and Operations | $91,773,135 |
| HVSI: Strategic Information | $29,130,748 |
| HLAB: Laboratory Infrastructure | $14,002,707 |
| OHSS: Health Systems Strengthening | $9,659,959 |
| HTXS: Treatment: Adult Treatment | $5,792,942 |
| HVTB: Care: TB/HIV | $4,540,432 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,744,591 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,357,354 |
| HVCT: Testing: HIV Testing and Counseling | $3,092,864 |
| HBHC: Care: Adult Care and Support | $3,014,861 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,816,847 |
| PDTX: Treatment: Pediatric Treatment | $1,060,416 |
| HMBL: Biomedical Prevention: Blood Safety | $840,535 |
| PDCS: Care: Pediatric Care and Support | $667,751 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $507,813 |
| HTXD: Treatment: ARV Drugs | $443,522 |
| HKID: Care: Orphans and Vulnerable Children | $403,188 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $357,035 |
| HMIN: Biomedical Prevention: Injection Safety | $285,852 |